Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Crescita Therapeutics Inc (CRRTF)

Crescita Therapeutics Inc (CRRTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Topical Drug Delivery Market by 2026: Key Competitors are Valeant Pharmaceuticals International, Inc., Crescita Therapeutics Inc., Medpharm

(MENAFN - CDN Newswire) The  Topical Drug Delivery Market  report includes a range of inhibitors as well as driving forces of the market which are analysed in both qualitative and quantitative approach...

ABBV : 92.67 (+2.93%)
ACRS : 1.4100 (+5.22%)
AGN : 193.02 (+0.02%)
ATRS : 2.87 (-1.37%)
BAYRY : 17.0999 (-0.76%)
CRRTF : 0.4463 (-10.74%)
HTSUF : 42.0500 (unch)
PFE : 38.19 (+0.03%)
VRX.TO : 30.80 (-3.33%)
Topical Drug Delivery Market by 2026: Key Competitors are Valeant Pharmaceuticals International, Inc., Crescita Therapeutics Inc., Medpharm

The report includes a range of inhibitors as well as driving forces of the market which are analysed in both qualitative and quantitative approach so that readers and users get precise information and...

ABBV : 92.67 (+2.93%)
ACRS : 1.4100 (+5.22%)
AGN : 193.02 (+0.02%)
ATRS : 2.87 (-1.37%)
CRRTF : 0.4463 (-10.74%)
HTSUF : 42.0500 (unch)
PFE : 38.19 (+0.03%)
VRX.TO : 30.80 (-3.33%)
Crescita Reports First Quarter 2020 Results

Positive Adjusted EBITDA 1  and Cash Flow

CTX.TO : 0.62 (-7.46%)
CRRTF : 0.4463 (-10.74%)
Crescita Reports First Quarter 2020 Results

Positive Adjusted EBITDA(1) and Cash Flow

CRRTF : 0.4463 (-10.74%)
CTX.TO : 0.62 (-7.46%)
Topical Drug Delivery Market Analysis as per the Latest Coronavirus Impact

BAYRY : 17.0999 (-0.76%)
CRRTF : 0.4463 (-10.74%)
NVS : 87.43 (+1.33%)
VRX.TO : 30.80 (-3.33%)
Crescita Therapeutics Announces the Results of its Annual General Meeting of Shareholders

, /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research...

CRRTF : 0.4463 (-10.74%)
CTX.TO : 0.62 (-7.46%)
Crescita Therapeutics Announces the Results of its Annual General Meeting of Shareholders

LAVAL, QC , May 14, 2020 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology...

CTX.TO : 0.62 (-7.46%)
CRRTF : 0.4463 (-10.74%)
Topical Drug Delivery Market 2020 Top Growing Companies, Structure Inspection and Forecast 2025

The Global is segmented on the lines of its producttype, facility of use, route of administration and regional. Based on product type segmentation it covers formulation, devices.Based on facility of use...

BAYRY : 17.0999 (-0.76%)
CRRTF : 0.4463 (-10.74%)
NVS : 87.43 (+1.33%)
VRX.TO : 30.80 (-3.33%)
Topical Drug Delivery Market (2020 to 2027) – Regional Analysis and Forecasts by Treatment Type, End User and Country Set for Rapid Growth and Trend by 2027

The Global is segmented on the lines of its producttype, facility of use, route of administration and regional. Based on product type segmentation it covers formulation, devices.Based on facility of use...

BAYRY : 17.0999 (-0.76%)
CRRTF : 0.4463 (-10.74%)
NVS : 87.43 (+1.33%)
VRX.TO : 30.80 (-3.33%)
Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") today announced that pursuant to the exemption provided in Ontario Instrument 51-502 - Temporary Exemption from Certain...

CRRTF : 0.4463 (-10.74%)
CTX.TO : 0.62 (-7.46%)
Crescita Therapeutics Announces Extension of First Quarter 2020 Filings Due to COVID-19

LAVAL, QC , April 28, 2020 /PRNewswire/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company") today announced that pursuant to the exemption provided in Ontario Instrument...

CTX.TO : 0.62 (-7.46%)
CRRTF : 0.4463 (-10.74%)
Topical Drug Delivery Market Detailed Analysis and Forecast by 2025

BAYRY : 17.0999 (-0.76%)
CRRTF : 0.4463 (-10.74%)
NVS : 87.43 (+1.33%)
VRX.TO : 30.80 (-3.33%)
Topical Drug Delivery System Market Growth, Size, Share, Trends, Status and Forecast 2020-2027

A new research report titled “” successfully exhibits the complete scenario of the global and an individual analysis of the various regional segments.

BAYRY : 17.0999 (-0.76%)
CRRTF : 0.4463 (-10.74%)
NVS : 87.43 (+1.33%)
VRX.TO : 30.80 (-3.33%)
Crescita Therapeutics Announces Measures in Response to COVID-19 Virus

Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development ("R&D")...

CRRTF : 0.4463 (-10.74%)
CTX.TO : 0.62 (-7.46%)
Crescita Therapeutics Announces Measures in Response to COVID-19 Virus

LAVAL, QC , March 24, 2020 /PRNewswire/ - Crescita Therapeutics Inc. ( TSX: CTX)  ( OTC US: CRRTF ) ("Crescita" or the "Company"), a growth-oriented, innovation-driven Canadian commercial...

CTX.TO : 0.62 (-7.46%)
CRRTF : 0.4463 (-10.74%)
Topical Drug Delivery Market 2020 Demand, Current Trends, Growth Analysis, Competitor Analysis, Future Forecast 2025

The Global is segmented on the lines of its product type, facility of use, route of administration and regional. Based on product type segmentation it covers formulation, devices. Based on facility of...

BAYRY : 17.0999 (-0.76%)
CRRTF : 0.4463 (-10.74%)
NVS : 87.43 (+1.33%)
VRX.TO : 30.80 (-3.33%)
BHC : 18.48 (-0.54%)
Crescita Reports Q4 and Fiscal 2019 Results

Record Annual Revenue of $22.3M Record Adjusted EBITDA of $7.0M up from $1.5M

CRRTF : 0.4463 (-10.74%)
Crescita Reports Q4 and Fiscal 2019 Results

Record Annual Revenue of $22.3M Record Adjusted EBITDA of $7.0M up from $1.5M

CTX.TO : 0.62 (-7.46%)
CRRTF : 0.4463 (-10.74%)
Topical Drug Delivery Market Size & Share Statistics and Growth Opportunities 2020-2025 – MRE

The Global Topical Drug Delivery Market is expected to exceed more than US$ 140 Billion by 2024 at a CAGR of 6% in the given forecast period.

BAYRY : 17.0999 (-0.76%)
CRRTF : 0.4463 (-10.74%)
NVS : 87.43 (+1.33%)
VRX.TO : 30.80 (-3.33%)
GSK : 41.92 (+0.91%)
Topical Drug Delivery System Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2020 to 2027

MENAFN12022020007010238ID1099690406

CRRTF : 0.4463 (-10.74%)
JNJ : 148.75 (+1.21%)
NVS : 87.43 (+1.33%)
VRX.TO : 30.80 (-3.33%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.79 , SEDG +6.61 , THC -1.40 , TER +2.46 , LITE +1.03
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar